Clinical Drug Experience Knowledgebase

autologous mononuclear stem cell (2 trials)

carboplatin (paraplatin) (1 trial)

carmustine (bicnu) (3 trials)

chlorambucil (Leukeran) (2 trials)

cytarabine (cytosar-u) (5 trials)

etoposide (vepesid) (2 trials)

ifosfamide (ifex) (2 trials)

naltrexone (revia) (6 trials)

rituximab (rituxan) (12 trials)

thiotepa (3 trials)

urea (1 trial)

zanubrutinib (Brukinsa) (1 trial)

acalabrutinib (calquence) (1 trial)

bendamustine (treanda) (1 trial)

bortezomib (velcade) (2 trials)

clarithromycin (biaxin) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

doxorubicin (Doxil) (2 trials)

doxycycline (vibramycin) (2 trials)

everolimus (zortress) (1 trial)

ibrutinib (imbruvica) (1 trial)

idarubicin (idamycin) (1 trial)

lenalidomide (revlimid) (2 trials)

methotrexate (1 trial)

pembrolizumab (keytruda) (1 trial)

prednisone (meticorten) (2 trials)

procarbazine (matulane) (1 trial)

tafasitamab (Monjuvi) (1 trial)

temozolomide (temodar) (1 trial)

vincristine (oncovin) (2 trials)